Nurix Therapeutics, Inc. (NRIX) Financials

NRIX Assets vs Liabilities
DateAssetsLiabilities
Aug. 31, 2026 1.2 billion 227.0 million
May 31, 2026 535.5 million 132.9 million
Feb. 28, 2026 636.1 million 155.2 million
Nov. 30, 2025 688.1 million 149.4 million

NRIX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Aug. 31, 2026 614.2 million 10.8 million
May 31, 2026 -98.5 million 11.4 million
Feb. 28, 2026 -73.0 million 9.4 million
Nov. 30, 2025 -73.0 million 9.1 million

NRIX Net Income

No data available :(

NRIX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Aug. 31, 2026 1.0 billion - 65.3 million
May 31, 2026 443.5 million - 58.1 million
Feb. 28, 2026 540.7 million - 58.7 million
Nov. 30, 2025 592.9 million - 55.7 million

NRIX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Aug. 31, 2026 116.2 million
May 31, 2026 111.1 million
Feb. 28, 2026 110.1 million
Nov. 30, 2025 95.1 million

NRIX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Aug. 31, 2026 1.4 million 79.3 million 34.4 million -
May 31, 2026 1.9 million 87.7 million 15.6 million -
Feb. 28, 2026 1.0 million 84.1 million 14.6 million -
Nov. 30, 2025 5.1 million 80.9 million 13.6 million -

NRIX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Aug. 31, 2026 673.1 million 2.1 million
May 31, 2026 9.0 million 3.9 million
Feb. 28, 2026 6.3 million 84.1 million
Nov. 30, 2025 13.6 million 4.6 million

NRIX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

NRIX

Price: $26.80

52 week price:
9.00
28.23

Earnings Per Share: 2.43 USD

P/E Ratio: 10.05

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 161700

Market Capitalization: 2.7 billion

Links: